Artemis Medicare Services Limited

ARTEMISMED
NSE· Healthcare
₹270.75
+1.40 (+0.52%)
Updated 12:20 pm IST
52W Low · ₹207.5052W High · ₹297.50
Near 52W High
Market Cap
₹3592.00L Cr
Volume
1.37L
Prev Close
₹275.40
ISIN
INE025R01021

Orion Score

Fundamentals-based quality & risk · not a recommendation

64/100
Watch

Artemis Medicare Services Limited scores 64/100 (Watch) on the Orion Score — moderate business quality (66), strong growth (83), moderate balance-sheet safety (56) and fair valuation (43). A fundamentals-based quality & risk score, not a buy/sell recommendation.

Quality
66
Growth
83
Safety
56
Value
43

Full Orion analysis

Risk checks

  • Profit converts to cash (CFO 1.9× PAT)
  • Low debt, comfortable interest cover
  • No distress, manipulation or dilution flags

Forensic accounting

Piotroski F 7/9Altman Z Safe(5.68)Beneish M Clean(-2.39)

Piotroski F = fundamental health (0–9, higher is better) · Altman Z = bankruptcy / distress risk · Beneish M = earnings-manipulation check

Technical / Momentum

Price Trend

59/100

Neutral

Technical momentum companion — separate from the fundamentals-based Orion Score.

Unlock with Pro

Upgrade →

VestAI Stock Score

VALUATION
Low Debt
D/E 0.28x — lean balance sheet
QUALITY
Average
ROCE 11.6% — decent returns
MOMENTUM
Neutral
RSI 52.2 — consolidating

Price Chart

SMA 20
SMA 50
SMA 200

Key Fundamentals

P/E Ratio
117.62
ROCE
11.63%
ROE (1Y)
11.63%
D/E Ratio
0.28x
OPM
—
TTM EPS
₹2.29
Dividend Yield
0.20%
Qtrly Sales
—
Qtrly Profit
—

Technical Signals

Peer Comparison — Healthcare

Top companies in the same sector by market cap

CompanyMkt CapP/EROCEROED/EOPM
ARTEMISMED ★₹3,592 Cr117.6211.63%11.63%0.28x—
SUNPHARMA₹4,27,609 Cr37.3215.73%14.72%0.06x18.90%
CIPLA₹1,14,609 Cr29.7613.66%11.74%0.02x9.50%
MAXHEALTH₹95,110 Cr66.2111.94%14.33%0.32x22.56%
AUROPHARMA₹88,228 Cr25.6412.55%9.93%0.21x15.11%
ASTERDM₹71,372 Cr108.608.93%10.07%0.46x13.98%

Shareholding Pattern

Q1 FY2027

Promoter
80.97%
FII
0.83%
DII
0.68%
Public
17.53%

Quarter-over-Quarter Trend

QuarterPromoterFIIDIIPublic
Q1 FY202780.97% ↓0.83% ↓0.68% ↓17.53% ↑
Q4 FY202680.99% ↑1% ↓0.82% ↓17.19% ↓
Q3 FY202658.38% ↓12.47% ↑2.91% ↓20.07% ↓
Q2 FY202666.53%0.37% ↑4.27% ↓21.81% ↑
Q1 FY202666.53% ↓0.24% ↓4.76% ↓21.45% ↑
Q4 FY202567.17%0.31% ↓5.04% ↑20.39% ↓
Q3 FY202567.17%0.65% ↑4.51% ↑20.59% ↓
Q2 FY202567.17%0.21%3.6%21.93%

Corporate Actions

Ex-DateActionDetails
2026-07-10
DIVIDEND
Dividend - Re 0.45 Per Share

Funds Holding This Stock

7 mutual fund schemes

1
LIC MF Healthcare Fund Direct GrowthLIC

2.87%

₹3 Cr

2
HSBC Focused Fund Direct GrowthHSBC

2.03%

₹34 Cr

3
LIC MF Focused Fund Direct GrowthLIC

1.98%

₹3 Cr

4
LIC MF Children's Fund Direct GrowthLIC

1.01%

₹0 Cr

5
Bandhan BSE Healthcare Index Fund Direct GrowthIDFC

0.09%

₹0 Cr

6
Bandhan Small Cap Fund Direct GrowthIDFC

0.06%

₹16 Cr

7
Motilal Oswal BSE 1000 Index Fund Direct GrowthMOTILAL_OSWAL

0.01%

₹0 Cr

Analyse ARTEMISMED with Orion AI

Ask: "Is Artemis Medicare Services Limited stock a good buy right now?" — Get RSI, MACD, ROCE + AI recommendation

Analyse with Orion

Want more insights like this?

Get free stock analysis, market insights, and investment ideas delivered to your inbox.

No spam. Unsubscribe anytime.

About Artemis Medicare Services Limited (ARTEMISMED) Stock

Artemis Medicare Services Limited is listed on the NSE under the Healthcare sector, Hospital industry. ISIN: INE025R01021. Track live share price, technical analysis, RSI, MACD, PE ratio, and smart money holdings on VestAI — India's AI-powered stock analysis platform.